NIH RFA · NIDCD · R61
RFA-DC-27-004: BRAIN Initiative: Exploratory Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R61 Clinical Trial Not Allowed)
Reviewed by Dr. Meng ZhaoLast reviewed October 16, 2026Data refreshed October 16, 2026Editorial standards
Invasive surgical procedures in humans offer the unique opportunity to intracranially record and stimulate neuronal activity within precisely localized brain structures, enabling high-impact human neuroscience investigations. This NOFO seeks exploratory research projects, from newly formed or established multi-disciplinary teams, to understand how dynamic activity of single cells and ensembles of neurons in spatially organized networks gives rise to the internal states we experience as sensations, perceptions, emotions, thoughts, and memories, and to observable motor and social behaviors. The research should be proposed as exploratory research and planning activities to establish…
- NOFO number
- RFA-DC-27-004
- Type
- RFA
- Activity code
- R61
- Primary institute
- NIDCD · National Institute on Deafness and Other Communication Disorders
- Clinical trials
- Not Allowed
- Posted
- May 4, 2026
- Opens
- May 9, 2026
- Expires
- Feb 12, 2027
RFA-DC-27-004 due dates
1 application due date remains before the NOFO expires. Dates marked * are NIH standard due dates. Check the related notices below for changes NIH made after posting.
| New | Renewal / Resubmission / Revision (as allowed) | AIDS - New/Renewal/Resubmission/Revision, as allowed | Scientific Merit Review | Advisory Council Review | Earliest Start Date |
|---|---|---|---|---|---|
| June 09, 2026 | June 09, 2026 | Not Applicable | November 2026 | January 2027 | April 2027 |
| February 11, 2027 | February 11, 2027 | Not Applicable | July 2027 | October 2027 | December 2027 |
What its predecessor RFA-DC-24-001 funded
RFA-DC-27-004 reissues RFA-DC-24-001. Until awards appear under the new number, its funding history is the best guide to who wins under this program: 4 projects and $8.3M in FY2022–FY2026.
Projects funded
4
Distinct projects, FY2022–FY2026
New awards
4
Type 1 (new project) award records
NIH funding
$8.3M
Award dollars under RFA-DC-24-001, FY2022–FY2026
Funding by fiscal year
| Fiscal year | Award records | New awards | Funding |
|---|---|---|---|
| FY2022 | 0 | 0 | $0 |
| FY2023 | 0 | 0 | $0 |
| FY2024 | 1 | 1 | $1.0M |
| FY2025 | 4 | 3 | $3.8M |
| FY2026 | 4 | 0 | $3.5M |
Institutions with the most funding
- University of Colorado Denver$2.8M · 1 project
- Cedars-Sinai Medical Center$2.0M · 1 project
- New York University School of Medicine$2.0M · 1 project
- University of Chicago$1.5M · 1 project
Funding institutes
- NIDCD$8.3M · 9
Activity codes funded
- R619 records
Most recent new awards
- Human hippocampal oscillations during visuomotor exploration (opens NIH RePORTER)
New York University School of Medicine · 1R61DC022830-01 · NIDCD · Notice Aug 23, 2025
$1.0MR61
- Neuronal mechanisms of learning and utilizing abstract representations (opens NIH RePORTER)
Cedars-Sinai Medical Center · 1R61DC022835-01 · NIDCD · Notice Aug 22, 2025
$1.1MR61
- Towards causal mapping of episodic memory iEEG networks via multi-method brain stimulation (opens NIH RePORTER)
University of Chicago · 1R61DC021925-01 · NIDCD · Notice Jun 11, 2025
$788KR61
- Neocortical microarchitecture of executive function using large-scale intracranial electrophysiology (opens NIH RePORTER)
University of Colorado Denver · 1R61DC021924-01 · NIDCD · Notice Aug 19, 2024
$1.0MR61
FY2026 closed on September 30, 2026, but NIH keeps posting that year's awards to RePORTER for several weeks. FY2026 figures reflect records available on October 16, 2026 and may rise slightly at the next refresh.
Participating institutes
10 NIH institutes and offices take applications under RFA-DC-27-004. Contact the program officer at the institute that fits your research before applying.
- NIDCD · National Institute on Deafness and Other Communication Disorders
- NEI · National Eye Institute
- NIA · National Institute on Aging
- NIAAA · National Institute on Alcohol Abuse and Alcoholism
- NIBIB · National Institute of Biomedical Imaging and Bioengineering
- NICHD · Eunice Kennedy Shriver National Institute of Child Health and Human Development
- NIDA · National Institute on Drug Abuse
- NIMH · National Institute of Mental Health
- NINDS · National Institute of Neurological Disorders and Stroke
- NCCIH · National Center for Complementary and Integrative Health
Related notices
NIH lists no related notices for RFA-DC-27-004 yet.
Award terms
- Application types allowed
- New Resubmission Revision The OER Glossary and the How to Apply Application Guide provide details on these application types. Only those application types listed here are allowed for this NOFO.
- Award budget
- Application budgets may not exceed 700,000 Direct Costs, exclusive of facilities and administrative costs for consortia) in any single year.
- Project period
- The scope of the proposed project should determine the project period. The maximum project period is 3 years. NIH grants policies as described in the NIH Grants Policy Statement will apply to the applications submitted and awards made from this NOFO.
- Funds available and number of awards
- Issuing IC and partner components intend to commit an estimated total of 6M total costs to fund approximately 5 awards per receipt date.
Summarized from the NOFO text; the full NOFO governs eligibility, budget, and review.
Related NOFOs
- Reissue of RFA-DC-24-001.
Other open NOFOs for R61
- RFA-OD-27-005INCLUDE Project: Clinical Trials Phased Awards for Down syndrome Research (R61/R33 Clinical Trial Required)OD · next due Jun 15, 2027
- PAR-25-158Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)NIAAA · next due Oct 19, 2026
- PAR-25-269NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)NCCIH · next due Oct 20, 2026
- PAR-25-225Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed)NINDS · next due Oct 20, 2026
- PAR-25-024Development of Biomarkers or Composite Biomarkers for Neurological and Neuromuscular Disorders (R61/R33 - Clinical Trial Optional)NINDS · next due Oct 20, 2026
- PAR-25-059Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed)NINDS · next due Oct 20, 2026
About this page
GotGrant gathers the NOFO, its participation and change notices, and its NOSIs from the NIH Guide for Grants and Contracts, and counts funded projects from NIH RePORTER by the opportunity number each award was made under. Data refreshed October 16, 2026; the NIH Guide is the authoritative source. See our data methodology.